Compare ARK Genomic Revolution ETF (ARKG) vs Halliburton Company (HAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Halliburton Company — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Halliburton Company trades at $34.75 (market cap $28.73B). The key difference: Halliburton Company pays a 1.98% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Halliburton Company nearer its low. Which is the better fit depends on your goals.
| ARKG | HAL | |
|---|---|---|
Sector | Sector/Thematic | Energy |
52-Week High | $43.57 | $42.98 |
52-Week Low | $23.09 | $20.50 |
Market Cap | — | $28.73B |
Enterprise Value | — | $34.81B |
Dividend Yield | — | 1.98% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Halliburton (HAL) trades at $34.39, up 0.79% with a bullish technical signal. The company shows solid fundamentals with a P/E of 19 and ROE of 14.56%, though recent earnings beat expectations with Q1 2026 EPS of $0.55 versus $0.50 expected. Recent developments include a key Iraq oilfield deal and digital transformation partnerships, supporting growth prospects in the oil services sector.
Outlook remains positive with analyst consensus price target of $44.00 (28% upside), though risks include oil price volatility and execution challenges. Revenue stability around $22B and strong cash flow generation provide fundamental support, while technical indicators suggest potential resistance near $35.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Halliburton Company
Halliburton is one of the three largest oilfield service firms in the world, offering superior expertise in a number of business lines, including completion fluids, wireline services, cementing, and countless others. It's the number one pressure pumper in North America, and has been a leading innovator in hydraulic fracturing over the last two decades.
Read more on HAL →
